Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Withdrawn 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Thoracic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 90Head and Neck Neoplasms 71Carcinoma, Non-Small-Cell Lung 31Thyroid Neoplasms 28Melanoma 24Ovarian Neoplasms 23Mouth Neoplasms 21Colorectal Neoplasms 19Oropharyngeal Neoplasms 18Carcinoma, Squamous Cell 16Uterine Cervical Neoplasms 15Carcinoma, Renal Cell 15Breast Neoplasms 15Lung Neoplasms 14Neoplasm Metastasis 13Nasopharyngeal Carcinoma 13Urinary Bladder Neoplasms 12Triple Negative Breast Neoplasms 12Stomach Neoplasms 12Laryngeal Neoplasms 12Sarcoma 11Prostatic Neoplasms 11Carcinoma 11Esophageal Neoplasms 10Endometrial Neoplasms 10Neoplasms 9Pancreatic Neoplasms 8Hypopharyngeal Neoplasms 8Salivary Gland Neoplasms 7Thyroid Cancer, Papillary 6

Interventions

ebselen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Ototoxicity × Head & Neck × 30 days × Clear all
NCT01451853 2026-06-03

SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss

Sound Pharmaceuticals, Incorporated

Phase 2 Withdrawn
Head & NeckThoracic

Ototoxicity, Deafness, Head and Neck Neoplasms, Lung Neoplasms, Tinnitus, Hearing Loss

NCT07622407 2026-06-03

TIMELY REHAB

VA Office of Research and Development

Phase NA Not yet recruiting
74 enrolled
Head & Neck

Ototoxicity, Deglutition Disorders, Head and Neck Neoplasms, Hearing Loss, Sensorineural, Tinnitus, Hearing Loss, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡